EUVIMEDEUVIMED entdecken
Open Access

Sexually Transmitted Infection (STI)/HIV Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022

Guoyu Tao, Chirag G Patel, Larry He, Kimberly Workowski

Clinical Infectious Diseases · 25.02.2026 · 82 (2) · e380-e386

DOI: 10.1093/cid/ciae314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 10.06.2024. Verfasst von Guoyu Tao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of STD Prevention, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Homosexuality, Male, Sexually Transmitted Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Routine sexually transmitted infection and human immunodeficiency virus (STI/HIV) testing and HIV pre-exposure prophylaxis (PrEP) use are recommended for men who have sex with men (MSM) at increased risk of HIV.

Methods

Using HealthVerity, a large administrative dataset in the United States, we assessed STI/HIV testing, chlamydia and gonorrhea positivity by specimen type, and HIV PrEP use among MSM and men who have sex with men and women (MSMW) at their first visits (index date) for those at increased risk of HIV and STIs from 2019 through 2022.

Results

Among 81 716 MSM and MSMW aged 15–64 years at their index date visit, STI testing rates were 57.9% for chlamydia, 58.1% for gonorrhea, and 52.2% for syphilis testing, respectively; 55.5%, 30.9%, and 18.1% had HIV testing, HIV PrEP use, and PrEP initiation, respectively, among the patients who did not have HIV. Of patients with chlamydia and gonorrhea testing, 48% were tested from the genital site only and 25% from 3 anatomic sites (rectal, pharyngeal, and urogenital). Chlamydia and gonorrhea positivity was 9.8% for chlamydia rectal infection, 7.3% for gonorrhea rectal infection, and 5.3% for gonorrhea pharyngeal infection.

Conclusions

Our results present current medical services provided during initial clinic visits for MSM and MSMW in private outpatient settings. Our study suggests that the assessment of STI/HIV testing is periodically needed due to the high prevalence of infection, and efforts to promote HIV PrEP for MSM and MSMW in private settings are urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-Exposure ProphylaxisHIV InfectionsHomosexuality, MaleSexually Transmitted DiseasesHIV TestingHumansAdultMaleUnited StatesYoung AdultAdolescentMiddle AgedFemaleGonorrheaChlamydia InfectionsMass Screening

Stichwörter der Autor:innen

HIV PrEP useMSMMSMWSTI/HIV testingchlamydia and gonorrhea positivity

Autor:innen und Institutionen

  • Division of STD Prevention, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
  • ORISE Fellow, Centers for Diseases Control and Prevention, Atlanta, Georgia, USA.
  • Department of Medicine, Emory University, Atlanta, Georgia, USA.

Förderung

  • Intramural CDC HHS

Zitieren

APA

Tao, G., Patel, C. G., He, L., & Workowski, K. (2026). Sexually Transmitted Infection (STI)/HIV Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022. Clinical Infectious Diseases, 82(2), e380-e386. https://doi.org/10.1093/cid/ciae314

Vancouver

Tao G, Patel CG, He L, Workowski K. Sexually Transmitted Infection (STI)/HIV Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022. Clinical Infectious Diseases. 2026;82(2):e380-e386. doi:10.1093/cid/ciae314

BibTeX
@article{Tao2026,
  author = {Tao, Guoyu and Patel, Chirag G and He, Larry and Workowski, Kimberly},
  title = {Sexually Transmitted Infection (STI)/HIV Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {82},
  number = {2},
  pages = {e380--e386},
  doi = {10.1093/cid/ciae314}
}
Kostenlos starten →